CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $90.27 --0%
EPS Growth %: +2.5%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
VFS, More
EPS Growth %: +2.5%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
VFS, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Upgrades Targa Resources (TRGP) to Buy, 'Wet Gas Fuels Growth'
- UBS Upgrades FTC Solar Inc. (FTCI) to Buy
- TD Cowen Reiterates Buy Rating on Dutch Bros Inc. (BROS)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
